abstract |
The present invention discloses yeast-based immunotherapeutic compositions, HBV antigens and fusion proteins for use in the treatment and/or prevention of hepatitis B virus (HBV) infection and its symptoms, and the use of such yeast-based immunotherapeutic compositions, HBV antigens and fusion proteins are used for prophylactic and/or therapeutic treatment of HBV and/or its symptoms. |